UBS downgrades Medline ($MDLN): here’s how the stock has reacted to similar analyst actions
How MDLN has reacted before
| Report | Next-day move |
|---|---|
| Jul 29, 2026 | +0.5% |
| Jun 12, 2026 | -1.4% |
| Jun 03, 2026 | +3.9% |
| Jun 02, 2026 | -7.2% |
| Jun 01, 2026 | -2.2% |
| Jan 21, 2026 | -1.9% |
| Jan 12, 2026 | +5.4% |
Median absolute move 2.2% · higher 3 of 7 · n=7
The call
- Firm: UBS
- Action: Downgrades
- Rating: Buy
- Price target: 50.00
How $MDLN moves around analyst actions
| Date | Session move |
|---|---|
| Jul 29, 2026 | +0.5% |
| Jun 12, 2026 | -1.4% |
| Jun 03, 2026 | +3.9% |
| Jun 02, 2026 | -7.2% |
| Jun 01, 2026 | -2.2% |
| Jan 21, 2026 | -1.9% |
| Jan 12, 2026 | +5.4% |
Base rate (last 7 instances):
- Median absolute move: 2.2%
- Higher: 3 of 7
- Biggest up: +5.4%
- Biggest down: -7.2%